Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Anti-infliximab, Anti-adalimumab and Anti-etanercept Antibodies in Children and Young Adolescents With Juvenile Idiopathic Arthritis

NCT01436019 is registered in ClinicalTrials.gov with Blood Transfusion Centre of Slovenia as lead sponsor.

NCT NCT01436019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01436019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Anti-infliximab, Anti-adalimumab and Anti-etanercept Antibodies in Children and Young Adolescents With Juvenile Idiopathic Arthritis
Lead sponsor
Blood Transfusion Centre of Slovenia
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2011
Completion date
December 31, 2012
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

juvenile idiopathic arthritis